DiaMedica Therapeutics Inc.DMAC
Market cap
$375.66M
P/E ratio
| 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Cash from operations | -6 | -9 | -9 | -12 | -11 | -19 | -22 |
| Capital expenditures | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Cash from investing | -0 | -4 | -16 | -21 | 12 | -18 | 9 |
| Cash from financing | 21 | 0 | 29 | 30 | -0 | 37 | 12 |
| Free cash flow | |||||||
| FCF margin (%) | - | - | - | - | - | - |